Concomitant use of direct oral anticoagulants and interacting antiarrhythmic drugs and the risk of stroke and bleeding among patients with non-valvular atrial fibrillation: a multinational cohort study [PDF]
BMC MedicineBackground Several antiarrhythmic drugs can interact with direct oral anticoagulants (DOACs) through pharmacokinetic mechanisms increasing DOAC levels. Our multinational cohort study assessed the effectiveness and safety of concomitant use of DOACs and ...
Fabian Maximilian Meinert +5 more
doaj +2 more sources
Historical Aspects of the Use of Antiarrhythmic Drugs in Clinical Practice
Рациональная фармакотерапия в кардиологии, 2022 Heart rhythm disorders are one of the most urgent problems in cardiology. The first reports on the possibility of using drugs in the treatment of cardiac arrhythmias began to appear in the scientific literature from the middle of the 18th century.
V. L. Doshchitsin, A. I. Tarzimanova
doaj +1 more source
Safety and interaction of direct oral anticoagulants with antiarrhythmic drugs
Российский кардиологический журнал, 2021 The use of direct oral anticoagulants minimized the risks associated with vitamin K antagonist (warfarin) therapy. Currently, direct oral anticoagulants have priority over warfarin for the prevention of thromboembolic events in patients with atrial ...
B. A. Tatarsky, N. V. Kazyonnova
doaj +1 more source
Российский кардиологический журнал, 2020 Aim. To individualize premature ventricular contraction (PVC) therapy in patients without structural cardiac changes by identifying potentially effective antiarrhythmic agents.Material and methods.
A. I. Olesin +3 more
doaj +1 more source
Antiarrhythmic Drug Dosing in Children—Review of the Literature
Children, 2023 Antiarrhythmic drugs represent a mainstay of pediatric arrhythmia treatment. However, official guidelines and consensus documents on this topic remain scarce. There are rather uniform recommendations for some medications (including adenosine, amiodarone,
Nathalie Oeffl +8 more
doaj +1 more source
1C-INDUCED ATRIAL FLUTTER IN A PATIENT WITH WPW SYNDROME: CASE REPORT AND REVIEW
Рациональная фармакотерапия в кардиологии, 2015 The clinical case of a rare proarrhythmic effect of antiarrhythmic drugs with a poor prognosis (medication-induced atrial flutter in a patient with "malignant" Kent’s bundle) is presented.
R. R. Mamatkazina +4 more
doaj +3 more sources
Adverse reactions of amiodarone [PDF]
, 2019 Adverse drug reaction is defined by the World Health Organization as any response to a drug that is noxious and unintended and occurs at a dose normally used in man.
Calvosa, Leonardo +5 more
core +1 more source
Cardiac Potassium Channels: Physiological Insights for Targeted Therapy. [PDF]
, 2017 The development of novel drugs specifically directed at the ion channels underlying particular features of cardiac action potential (AP) initiation, recovery, and refractoriness would contribute to an optimized approach to antiarrhythmic therapy that ...
A. John Camm +14 more
core +1 more source
Current strategies of antiarrhythmic drug therapy for paroxysmal atrial fibrillation
Journal of Arrhythmia, 2012 Atrial fibrillation is now recognized as a significant medical and social problem. Atrial fibrillation not only causes cardiovascular complications, including thromboembolism and heart failure, but also decreases the survival of patients with impaired ...
Takashi Komatsu
doaj +1 more source
Arrhythmia induction using isoproterenol or epinephrine during electrophysiology study for supraventricular tachycardia [PDF]
, 2018 Background Electrophysiology study (EPS) is an important part of the diagnosis and workup for supraventricular tachycardia (SVT). Provocative medications are used to induce arrhythmias, when they are not inducible at baseline. The most common medication
Padanilam, Benzy J. +4 more
core +1 more source